The high incidence of rectal cancer in both sexes makes it one of the most common tumors,
with significant morbidity and mortality rates. To define the best treatment option and …

Until recently, cancer registries have only collected cancer clinical stage at diagnosis, before
any therapy, and pathological stage after surgical resection, provided no treatment has been …

Background Systemic relapses remain a major problem in locally advanced rectal cancer.
Using short-course radiotherapy followed by chemotherapy and delayed surgery, the Rectal …

Neoadjuvant chemo-radiotherapy (CRT) followed by total mesorectal excision (TME)
represents the standard treatment for patients with locally advanced (≥ T3 or N+) rectal …

Abstract “Node-RADS” addresses the lack of consensus in the radiologic assessment of
lymph node involvement by cancer and meets the increasing demand for structured …

Background In patients with rectal cancer, enlarged lateral lymph nodes (LLNs) result in
increased lateral local recurrence (LLR) and lower cancer-specific survival (CSS) rates …

Background Magnetic resonance imaging (MRI)-based lymph node staging remains a
significant challenge in the treatment of rectal cancer. Pretreatment evaluation of lymph …

The evaluation of the efficacy of different therapies is of paramount importance for the
patients and the clinicians in oncology, and it is usually possible by performing imaging …

While cross-sectional imaging has seen continuous progress and plays an undiscussed
pivotal role in the diagnostic management and treatment planning of patients with rectal …

Background and purpose Comprehensive dosimetric analysis is required prior to the clinical
implementation of pelvic MR-only sites, other than prostate, due to the limited number of site …